Cases & Deals

DT Capital invests in China Biologic

Clients DT Capital Partners

Jones Day advised DT Capital Partners in connection with its purchase of $7.5 million of Convertible Notes and Warrants in a private placement by China Biologic Products, Inc., a biopharmaceutical company that engages in the research, development, production, and manufacturing of plasma-based pharmaceutical products in China.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.